About Medigus Ltd.
Medigus develops the MUSE system, a transoral incisionless fundoplication device using ultrasound-guided stapling to treat gastroesophageal reflux disease (GERD) endoscopically.
📍 Location & Offices
📋 Request a Quote
Send your requirements directly to Medigus Ltd.. Response typically within 48 hours.
Company Info
TypePublic
StockMDGS (NASDAQ)
Founded1999
Employees60
Revenue$8M
HQOmer, Israel